Related Experiment Videos

Comparative study of clinical characteristics between Chinese Han and German Caucasian patients with coronary heart

Yali Zheng1, Wenfei Ma, Yan Zeng

  • 1Department of Internal Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefangdadao 1095, 430030, Wuhan, China.

Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|September 19, 2009
PubMed

Insights

Coronary heart disease (CHD) patients show significant differences in risk factors and treatment between Chinese Han and German Caucasians. Chinese patients had higher hospitalization rates and smoking ratios, while Germans had more comorbidities.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Public Health

Background:

  • Clinical characteristics, risk factors, treatment, and prognosis of coronary heart disease (CHD) vary across different populations.
  • Limited research exists on the specific differences between Chinese Han and German Caucasian CHD patients.

Purpose of the Study:

  • To compare the clinical characteristics, risk factors, and treatment strategies of CHD in Chinese Han and German Caucasian populations.
  • To identify key differences that may influence patient outcomes and inform tailored healthcare approaches.

Main Methods:

  • A comparative analysis of clinical data and blood examination results was conducted.
  • Data from 650 Chinese Han and 640 German Caucasian patients diagnosed with CHD were collected and analyzed.

Main Results:

  • Chinese patients exhibited higher first hospitalization rates for CHD (95.1% vs. 38.1%) and a higher ratio of smoking and acute myocardial infarction.
  • German patients presented with more comorbidities, including hypertension, dyslipidemia, and abnormal glucose metabolism, alongside higher levels of fibrinogen, homocysteine, and obesity.
  • Treatment disparities were observed, with lower utilization of statins, beta-blockers, and ACE inhibitors/ARBs in Chinese patients, and lower rates of percutaneous coronary intervention and coronary artery bypass grafting, although drug-eluting stent usage was higher.

Conclusions:

  • Significant differences exist in the clinical presentation, risk factor profiles, and treatment modalities for coronary heart disease between Chinese Han and German Caucasian populations.
  • These variations underscore the need for culturally and ethnically tailored strategies in CHD prevention and management.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...